Trial Profile
Multicenter, Randomized, Parallel Study of Spherical Adsorptive Carbon (KREMEZIN) in Patients with Early Stage Chronic Kidney Disease of Nephropathy due to Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2012
Price :
$35
*
At a glance
- Drugs Charcoal (Primary) ; ACE inhibitors; Angiotensin receptor antagonists
- Indications Diabetic nephropathies; Renal failure
- Focus Therapeutic Use
- 24 Jan 2012 New trial record